Abbott Laboratories (FRA:ABL)
110.48
-2.32 (-2.06%)
At close: Aug 1, 2025, 10:00 PM CET
Marathon Oil Revenue
Abbott Laboratories had revenue of $11.14B USD in the quarter ending June 30, 2025, with 7.37% growth. This brings the company's revenue in the last twelve months to $43.11B, up 5.85% year-over-year. In the year 2024, Abbott Laboratories had annual revenue of $41.95B with 4.59% growth.
Revenue (ttm)
$43.11B
Revenue Growth
+5.85%
P/S Ratio
5.23
Revenue / Employee
$378.15K
Employees
114,000
Market Cap
191.88B
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 41.95B | 1.84B | 4.59% |
Dec 31, 2023 | 40.11B | -3.54B | -8.12% |
Dec 31, 2022 | 43.65B | 578.00M | 1.34% |
Dec 31, 2021 | 43.08B | 8.47B | 24.47% |
Dec 31, 2020 | 34.61B | 2.70B | 8.48% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SAP SE | 35.89B |
Siemens Aktiengesellschaft | 77.82B |
Deutsche Telekom AG | 120.25B |
Allianz SE | 109.03B |
Siemens Energy AG | 37.44B |
Rheinmetall AG | 10.48B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 61.84B |
Deutsche Bank Aktiengesellschaft | 30.07B |
Abbott Laboratories News
- 3 days ago - Paul MacDonald's Top Picks: Stryker, Abbott Labs & Elevance Health - BNN Bloomberg
- 4 days ago - Best Dividend Aristocrats For August 2025 - Seeking Alpha
- 9 days ago - Five years after COVID, pharma shares languish in US policy limbo - Reuters
- 10 days ago - Best Dividend Kings: July 2025 - Seeking Alpha
- 12 days ago - Notable healthcare headlines for the week: Trump’s tariff threats, J&J, Abbott Laboratories and Sarepta in focus - Seeking Alpha
- 14 days ago - Looking Into Abbott Laboratories's Recent Short Interest - Benzinga
- 14 days ago - Analysts defend Abbott Labs' stock after Thursday's 'too punitive' sell-off - CNBC
- 14 days ago - tech giants stumble as Tesla accelerates: Unpacking today's mixed market signals - Forexlive